C
The startup develops a novel platform for designing oral vaccines using a streamlined formulation process that reduces production costs and time-to-market. This approach enhances safety and efficacy, addressing the challenges of traditional vaccine delivery methods.
Updated 4 months ago
Funding
$800K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a novel platform for designing oral vaccines using a streamlined formulation process that reduces production costs and time-to-market. This approach enhances safety and efficacy, addressing the challenges of traditional vaccine delivery methods.